The ICGEB Biotechnology Development Unit (BDU) and Elettra Sincrotrone Trieste have organised the 19th Annual Meeting of the Protein Production and Purification Partnership in Europe, with the patronage of AREA Science Park.
The 19th Annual Meeting of the Protein Production and Purification Partnership in Europe took place in Trieste on 22-23 May 2023 under the auspices of the AREA Science Park, organised by Elettra Sincrotrone Trieste and the ICGEB Biotechnology Development Unit, headed by Dr. Natasa Skoko.
The P4EU Partnership groups more than 150 biotechnology experts working on the production and characterisation of proteins, with the mission of facilitating communication and exchange of information. The annual meeting brought together more than 80 participants from Europe, Israel and the USA, who are experts from across research organisations, universities and the private sector working in the field. This high-level scientific event is centred around new expression and purification technologies, protein characterisation expert panels, process optimisation, quality control and new applications.
ICGEB hosted a Technical Workshop on biophysical methods for protein quality control including Mass Photometry and Methods applied at Elettra for protein fold and binding analysis.
Dr. Paola Storici, Head of the Protein Facility at the Elettra Sincrotrone, Prof. Caterina Petrillo, President of AREA Science Park and Dr. Skoko welcomed the international attendees of the 19th P4EU Meeting, underlining the common mission of linking basic research to the market for the benefit of society.
“The BDU has been active for 30 years, developing production processes for therapeutic recombinant proteins, to perform non-exclusive technology transfer,” explained Dr. Skoko, who continued: “the ICGEB works in synergy with almost 70 Member States on topics aligned with the Sustainable Development Goals of the United Nations. The BDU provides hands-on practical training and technology transfer to industrial and institutional partners worldwide.”
“The capability to edit cell lines, high-throughput cell selection, scale-up of the production processes and chemical modifications enable the BDU to enter various scientific collaborations and provide services to the industry”, she concluded.
Further reading:
